Tg Therapeutics Inc (TGTX)

R&D to Revenue

39.67%

Quarterly · Period ending:

TGTX logo

TGTX R&D to Revenue

Latest reported39.67%
TGTX Quarterly R&D/Revenue (0.00% → 39.67%)
High-resolution chart · PNG

TGTX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
39.6684%
23.6173%
21.3907%
25.2787%
22.5168%
38.3614%
22.0678%
24.0084%
23.8968%
51.5518%
39.683%
8.8973%
139.7163%
203.3833%
37,043.75%
22,128.7234%
4,524.2424%
2,383.0357%
2,699.0952%
2,559.9507%
2,904.2718%
7,956.3682%
113,055.2632%
132,800%
95,918.4211%
94,794.7368%
77,510.5263%
148,692.1053%
82,931.5789%
81,305.2632%
134,392.1053%
86,194.7368%
99,505.2632%
84,628.9474%
67,557.6874%
66,502.4202%
66,779.0445%
53,486.7935%
56,213.9992%
54,803.9374%
34,037.4695%
29,480.0236%
36,030.7809%
30,287.29%
25,993.4742%
21,733.6422%
33,619.9081%
32,788.214%
9,313.6133%
6,584.2184%
9,466.8198%
8,237.3976%
12,236.3959%
3,189.9252%
4,516.0752%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
-2,757.0477%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
27.987%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.